Lincoln Pharmaceuticals Ltd (LINCOLN)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 551.50
% Change: -0.85% (Prev Close: 556.25)

Volume: 19,406
% Change: 9.41% (Prev Volume: 17,737)

Delivery: 12,458
Delivery % : 64.20
% Change: 10.65% (Prev Delivery: 11,259)

Turnover: 107 Lacs
% Change: 7.95% (Prev Turnover: 99)

💹 EOD Valuation

P/E Ratio: 12.79
P/B Ratio: 1.64
Market Cap: 1103 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: LINCOLN
Market Cap: 1079 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 979.50
52 Week Low: 499.00

All-Time High: 979.50 Rs.
All-Time Low: 14.75 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
3.89% | -2.60% | -1.87% | -22.19% | 24.41%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 49.78%

Change (3Y | 1Y): 5.70% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 5.13%

Change (3Y | 1Y): 4.49% | 0.13%

DII Holding

DII Holding: 0.01%

Change (3Y | 1Y): 0.01% | 0.01%

Public Holding: 45.08%


🏦 Financial Strength

Debt to Equity: 0.00
Debt: 0.00 Rs. Cr.

Book Value: 335.34 Rs.
Current Ratio: 4.71
Interest Coverage: 70.34
Free Cash Flow: 73.90 Rs. Cr.


📈 Growth & Sales

Sales Growth: 6.38%

Sales Growth Qtr (YOY | QoQ):
4.61% | -8.39%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
10.03% | 9.70% | 6.38%


💰 Profit & Earnings

Profit Growth %

Profit Growth: -11.84%

Profit Growth Qtr (YOY | QoQ):
16.94% | 139.03%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
9.86% | 6.20% | -11.84%


EPS Rs.

EPS (TTM): 43.12 Rs.

EPS Qtr (Last Year | Latest):
11.82 Rs. | 13.82 Rs.

EPS Annual (Last Annual | Annual March):
46.58 Rs. | 41.11 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
9.82% | 6.20%


Net Profit Rs. Cr.

Net Profit (TTM): 86.36 Rs. Cr.

Net Profit (Annual - March): 82.35 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
23.67| 11.58 | 27.68


EBITDA Rs. Cr.

EBITDA (Quarter): 39.08 Rs. Cr.
EBITDA (Previous Yr Ql): 33.14 Rs. Cr.

EBITDA (Annual - March): 123.97 Rs. Cr.
EBITDA (Previous Annual): 132.93 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
10.10% | 5.81%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 16.28%

OPM Qtr (Previous | Current):
15.89% | 15.45%

OPM Annual (5 Yrs | Last Yr | March):
18.17% | 17.26% | 16.28%


Return on Equity %

ROE: 13.02%

ROE (5 Yrs | 3 Yrs | Last Yr):
15.84% | 15.00% | 16.84%


Return on Capital Employed %

ROCE: 17.55%

ROCE (5 Yrs | 3 Yrs | Last Yr):
22.11% | 20.51% | 22.27%


Return on Assets %

ROA (TTM): 11.00%

ROA (5 Yrs | 3 Yrs | Last Yr):
13.40% | 12.75% | 14.32%



PEG Ratio: 2.01
Dividend Yield: 0.33%

PE 3 Yrs: 13.14
PE 5 Yrs: 11.03

Dividend Yield: 0.33%


👥 Company

Lincoln Pharmaceuticals Ltd

LINCOLN

Promoter Holding: %